230000035897 transcription Effects 0.000 claims description 15.108091008117 polyclonal antibodies Proteins 0.000 claims description 15.238000005516 engineering process Methods 0.000 claims description 15.238000004519 manufacturing process Methods 0.000 claims description 16.239000008194 pharmaceutical composition Substances 0.000 claims description 24.201000000050 myeloid neoplasm Diseases 0.000 claims description 25.230000005540 biological transmission Effects 0.000 claims description 25.230000018109 developmental process Effects 0.000 claims description 26.108010061543 Neutralizing Antibodies Proteins 0.000 claims description 29.125000000539 amino acid group Chemical group 0.000 claims description 31.206010035226 Plasma cell myeloma Diseases 0.000 claims description 39.239000003795 chemical substances by application Substances 0.000 claims description 41.210000000988 Bone and Bones Anatomy 0.000 claims description 47. 238000004458 analytical method Methods 0.000 claims description 54.108060003951 Immunoglobulins Proteins 0.000 claims description 54.102000018358 Immunoglobulins Human genes 0.000 claims description 54.102000005614 monoclonal antibodies Human genes 0.000 claims description 63.108010045030 monoclonal antibodies Proteins 0.000 claims description 64.229920001850 Nucleic acid sequence Polymers 0.000 claims description 98.230000014509 gene expression Effects 0.000 claims description 117.125000003275 alpha amino acid group Chemical group 0.000 claims description 191.239000000203 mixture Substances 0.000 title claims description 179.108090001123 antibodies Proteins 0.000 title claims abstract description 794.102000004965 antibodies Human genes 0.000 title claims abstract description 794.Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.) Filing date Publication date Priority to US75921606P priority Critical Application filed by Новартис Аг filed Critical Новартис Аг Priority to PCT/US2007/000777 priority patent/WO2007084344A2/en Publication of EA200801679A1 publication Critical patent/EA200801679A1/en Publication of EA015538B1 publication Critical patent/EA015538B1/en Links Google Patents Compositions and methods of use for antibodies of dickkopf-1 and/or -4ĭownload PDF Info Publication number EA015538B1 EA015538B1 EA200801679A EA200801679A EA015538B1 EA 015538 B1 EA015538 B1 EA 015538B1 EA 200801679 A EA200801679 A EA 200801679A EA 200801679 A EA200801679 A EA 200801679A EA 015538 B1 EA015538 B1 EA 015538B1 Authority EA Eurasian Patent Office Prior art keywords antibody amino acid antibodies binding sequence Prior art date Application number EA200801679A Other languages Russian ( ru) Google Patents EA015538B1 - Compositions and methods of use for antibodies of dickkopf-1 and/or -4 EA015538B1 - Compositions and methods of use for antibodies of dickkopf-1 and/or -4
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |